Dec 15 (Reuters) - Australia's competition regulator said on Friday it had decided to oppose the proposed acquisition of Healius Limited (HLS) by Australian Clinical Labs. (ACL)
- Forums
- ASX - By Stock
- HLS
- News: HLS Australia's competition regulator opposes Australian Clinical Labs' offer to buy Healius
HLS
healius limited
Add to My Watchlist
0.91%
!
83.3¢

News: HLS Australia's competition regulator opposes Australian Clinical Labs' offer to buy Healius
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
83.3¢ |
Change
0.008(0.91%) |
Mkt cap ! $604.5M |
Open | High | Low | Value | Volume |
81.5¢ | 84.5¢ | 81.5¢ | $1.626M | 1.950M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 42484 | 83.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
83.5¢ | 19761 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
42 | 44145 | 0.830 |
27 | 118928 | 0.825 |
18 | 273505 | 0.820 |
8 | 65272 | 0.815 |
5 | 60558 | 0.810 |
Price($) | Vol. | No. |
---|---|---|
0.835 | 89 | 2 |
0.840 | 91669 | 14 |
0.845 | 24207 | 8 |
0.850 | 235403 | 11 |
0.855 | 548735 | 8 |
Last trade - 14.31pm 08/09/2025 (20 minute delay) ? |
Featured News
HLS (ASX) Chart |